Deregulated cyclooxygenase-2 expression in oral premalignant tissues

Molecular Cancer Therapeutics

Volumn 1, Issue 14, 2002, Pages 1265-1271

  Banerjee, Abhijit G ^a   Gopalakrishnan, Velliyur K ^a   Bhattacharya, Indraneel ^b   Vishwanatha, Jamboor K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; ISOENZYME; MEMBRANE PROTEIN; MESSENGER RNA; PROSTAGLANDIN SYNTHASE; PTGS2 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; CELL LINE; DISEASE COURSE; ENZYMOLOGY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MOLECULAR GENETICS; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CELL LINE, TRANSFORMED; CYCLOOXYGENASE 2; CYTOKINES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; MOUTH NEOPLASMS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0038718635     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. SEER Cancer Statistics Review 1973-1991. Gloeckler Ries, L. A., Miller, B. A., Hankey, B. F., Kosary, C. L., Harras, A., and Edwards, B. K. NIH-94-2789. 1994. US Department of Health and Human Services, Public Health Service, National Cancer Institute, 1994.
2. Cancers of the oral cavity and pharynx: a statistics review monograph, 1973-1987. Kleinman, D. V., Crossett, L. S., and Ries, L. A. G., 1991. Atlanta, US Department of Health and Human Services, Public Health Service, Centers for Disease Control.
3. Silverman, S., Jr., Gorsky, M., and Greenspan, D. Tobacco usage in patients with head and neck carcinomas: a follow-up study on habit changes and second primary oral/oropharyngeal cancers. J. Am. Dent. Assoc., 106: 33-35, 1983.
4. Blot, W. J., McLaughlin, J. K., Winn, D. M., Austin, D. F., Greenberg, R. S., Preston-Martin, S., Bernstein, L., Schoenberg, J. B., Stemhagen, A., and Fraumeni, J. F., Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res., 48: 3282-3287, 1988.
5. Nam, J. M., McLaughlin, J. K., and Blot, W. J. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among U. S. whites. J. Natl. Cancer Inst. (Bethesda), 84: 619-622, 1992.
6. The health consequences of using smokeless tobacco: a report of the surgeon general. NIH-86-2874, 1986. Bethesda, MD, US Public Health Service, US Department of Health and Human Services.
7. Kleinman, D. V., and Swango, P. A. Self-reported history of tobacco use by US school children, grades 6-12. Abstracts of the APHA 117th Annual Meeting, October 1989.
8. Mincer, H. H., Coleman, S. A., and Hopkins, K. P. Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia. Oral Surg. Oral Med. Oral Pathol., 33: 389-399, 1972.
9. Shafer, W. G., and Waldron, C. A. Erythroplakia of the oral cavity. Cancer (Phila.), 36: 1021-1028, 1975.
10. Williams, H. K. Molecular pathogenesis of oral squamous carcinoma. Mol. Pathol., 53: 165-172, 2000. (Pubitemid 30603069)
11. Park, N. H., and Kang, M. K. Genetic instability and oral cancer. J. Biotechnol., 3: 66-71, 2000. (Pubitemid 38956836)
12. Anderson, J. A., Irish, J. C., McLachlin, C. M., and Ngan, B. Y. H-ras oncogene mutation and human papillomavirus infection in oral carcinomas. Arch. Otolaryngol. Head Neck Surg., 120: 755-760, 1994. (Pubitemid 24217590)
13. Craven, J. M., Pavelic, Z. P., Stambrook, P. J., Pavelic, L., Gapany, M., Kelley, D. J., Gapany, S., and Gluckman, J. L. Expression of c-erbB-2 gene in human head and neck carcinoma. Anticancer Res., 12: 2273-2276, 1992. (Pubitemid 23105445)
14. Brachman, D. G., Graves, D., Vokes, E., Beckett, M., Haraf, D., Montag, A., Dunphy, E., Mick, R., Yandell, D., and Weichselbaum, R. R. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res., 52: 4832-4836, 1992.
15. Shindoh, M., Chiba, I., Yasuda, M., Saito, T., Funaoka, K., Kohgo, T., Amemiya, A., Sawada, Y., and Fujinaga, K. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression. Cancer (Phila.), 76: 1513-1521, 1995.
16. Shin, D. M., Kim, J., Ro, J. Y., Hittelman, J., Roth, J. A., Hong, W. K., and Hittelman, W. N. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res., 54: 321-326, 1994. (Pubitemid 24053159)
17. Boyle, J. O., Hakim, J., Koch, W., van-der, R. P., Hruban, R. H., Roa, R. A., Correo, R., Eby, Y. J., Ruppert, J. M., and Sidransky, D. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res., 53: 4477-4480, 1993.
18. Somers, K. D., Merrick, M. A., Lopez, M. E., Incognito, L. S., Schechter, G. L., and Casey, G. Frequent p53 mutations in head and neck cancer. Cancer Res., 52: 5997-6000, 1992.
19. Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold-Mende, C., Schuhmann, A., and Bosch, F. X. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Cancer Res., 53: 4189-4196, 1993. (Pubitemid 24146765)
20. Lee, J. I., Soria, J. C., Hassan, K., Liu, D., Tang, X., El Naggar, A., Hong, W. K., and Mao, L. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Cancer Res., 61: 837-841, 2001. (Pubitemid 32174388)
21. van-der, R. P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
22. Yamamoto, T., Kamata, N., Kawano, H., Shimizu, S., Kuroki, T., Toyoshima, K., Rikimaru, K., Nomura, N., Ishizaki, R., and Pastan, I. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res., 46: 414-416, 1986. (Pubitemid 16189082)
23. Santini, J., Formento, J. L., Francoual, M., Milano, G., Schneider, M., Dassonville, O., and Demard, F. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck, 13: 132-139, 1991.
24. Kaiser, U., Schardt, C., Brandscheidt, D., Wollmer, E., and Havemann, K. Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer. J. Cancer Res. Clin. Oncol., 119: 665-668, 1993. (Pubitemid 23238149)
25. Xu, X. C., Ro, J. Y., Lee, J. S., Shin, D. M., Hong, W. K., and Lotan, R. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues. Cancer Res., 54: 3580-3587, 1994. (Pubitemid 24225987)
26. Shin, D. M., Voravud, N., Ro, J. Y., Lee, J. S., Hong, W. K., and Hittelman, W. N. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J. Natl. Cancer Inst. (Bethesda), 85: 971-978, 1993. (Pubitemid 23177583)
27. Hansson, A., Bloor, B. K., Haig, Y., Morgan, P. R., Ekstrand, J., and Grafstrom, R. C. Expression of keratins in normal, immortalized and malignant oral epithelia in organotypic culture. Oral Oncol., 37: 419-430, 2001. (Pubitemid 32480279)
28. Chan, G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D., Soslow, R. A., Koki, A. T., Woerner, B. M., Masferrer, J. L., and Dannenberg, A. J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59: 991-994, 1999. (Pubitemid 29135955)
29. Tsujii, M., and Dubois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell, 83: 493-501, 1995.
30. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998. (Pubitemid 28257578)
31. Huang, M., Stolina, M., Sharma, S., Mao, J. T., Zhu, L., Miller, P. W., Wollman, J., Herschman, H., and Dubinett, S. M. Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res., 58: 1208-1216, 1998. (Pubitemid 28183210)
32. Park, N. H., Min, B. M., Li, S. L., Huang, M. Z., Cherick, H. M., and Doniger, J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis, 12: 1627-1631, 1991.
33. Klimp, A. H., Hollema, H., Kempinga, C., van der Zee, A. G., de Vries, E. G., and Daemen, T. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res., 61: 7305-7309, 2001. (Pubitemid 32946529)
34. Mei, J. M., Hord, N. G., Winterstein, D. F., Donald, S. P., and Phang, J. M. Expression of prostaglandin endoperoxide H synthase-2 induced by nitric oxide in conditionally immortalized murine colonic epithelial cells. FASEB J., 14: 1188-1201, 2000. (Pubitemid 30350401)
35. Nathan, C. A., Leskov, I. L., Lin, M., Abreo, F. W., Shi, R., Hartman, G. H., and Glass, J. COX-2 expression in dysplasia of the head and neck: correlation with elF4E. Cancer (Phila.), 92: 1888-1895, 2001. (Pubitemid 32952508)
36. Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., and Seibert, K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res., 60: 1306-1311, 2000. (Pubitemid 30151999)
37. Attiga, F. A., Fernandez, P. M., Weeraratna, A. T., Manyak, M. J., and Patierno, S. R. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Res., 60: 4629-4637, 2000. (Pubitemid 32103650)
38. Masunaga, R., Kohno, H., Dhar, D. K., Ohno, S., Shibakita, M., Kinugasa, S., Yoshimura, H., Tachibana, M., Kubota, H., and Nagasue, N. COX-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin. Cancer Res., 6: 4064-4068, 2000.
39. Zhang, H. T., Scott, P. A., Morbidelli, L., Peak, S., Moore, J., Turley, H., Harris, A. L., Ziche, M., and Bicknell, R. The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br. J. Cancer, 83: 63-68, 2000. (Pubitemid 30352718)
40. Munkarah, A. R., Morris, R., Baumann, P., Deppe, G., Malone, J., Diamond, M. P., and Saed, G. M. Effects of prostaglandin E (2) on proliferation and apoptosis of epithelial ovarian cancer cells. J. Soc. Gynecol. Investig., 9: 168-173, 2002. (Pubitemid 34497146)